Cristian Luput - 30 Jun 2023 Form 4 Insider Report for MAIA Biotechnology, Inc. (MAIA)

Role
Director
Signature
/s/ Cristian Luput
Issuer symbol
MAIA
Transactions as of
30 Jun 2023
Transactions value $
$0
Form type
4
Date filed
05 Jul 2023, 08:14
Previous filing
17 May 2023
Next filing
03 Oct 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MAIA Stock Options Award $0 +8.91K $0.00 8.91K 30 Jun 2023 Common Stock 8.91K $2.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options, granted on June 30, 2023 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.